Virtual Library

Start Your Search

Filter Results:

Show Only Available Presentations

  • +

    P08 - Health Services Research/Health Economics - Factors Affecting Clinical Outcomes

    • Type: Posters
    • Track: Health Services Research/Health Economics
    • Presentations: 5
    • Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
    • +

      P08.04 - Comparative Clinical Outcomes Between EGFR Exon20ins and Wildtype NSCLC Treated with Immune Checkpoint Inhibitors

      00:00 - 00:00  |  Presenter: Lyudmila Bazhenova

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    OA15 - Upcoming Molecular Targeted Agents for EGFR exon 20 Insertion and MET Skipping Mutation

    • Type: Oral
    • Track: Novel Therapeutics and Targeted Therapies
    • Presentations: 6
    • Moderators:Helena A Yu
    • Coordinates: 9/12/2021, 18:45 - 19:45, Program Auditorium
    • +

      OA15.01 - Mobocertinib in EGFR Exon 20 Insertion–Positive Metastatic NSCLC Patients With Disease Control on Prior EGFR TKI Therapy

      18:45 - 18:55  |  Presenter: Alexander Spira

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      OA15.02 - Phase 1 Studies of DZD9008, an Oral Selective EGFR/HER2 Inhibitor in Advanced NSCLC with EGFR Exon20 Insertion Mutations

      18:55 - 19:05  |  Presenter: Pasi A. Janne

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    ES20 - Caveats, Challenges, and Controversies in Immunotherapy of Lung Cancer: Phase II and Phase III Trials*

    • Type: Education Session
    • Track: Immunotherapy (Phase II/III Trials)
    • Presentations: 5
    *Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.
    • Moderators:David R. Gandara
    • Coordinates: 9/14/2021, 20:30 - 21:05, Program Auditorium